Brevan Howard Capital Management LP Vera Therapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 5,504 shares of VERA stock, worth $157,304. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,504
Previous 7,614
27.71%
Holding current value
$157,304
Previous $336,000
30.95%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$160 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$125 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$95.4 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$84.6 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$84.3 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $773M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...